Baird Financial Group
MLAB icon

Baird Financial Group’s Mesa Laboratories MLAB Stock Holding History

Baird Financial Group’s Portfolio MLAB Stock Details MLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,220
Closed -$249K – 1785
2022
Q2 		$249K Sell
1,220
-25
-2% -$5.47K ﹤0.01% 1618
2022
Q1 		$317K Sell
1,245
-20
-2% -$5.43K ﹤0.01% 1597
2021
Q4 		$415K Sell
1,265
-3
-0.2% -$942 ﹤0.01% 1553
2021
Q3 		$383K Buy
+1,268
New +$360K ﹤0.01% 1581

Other funds holding MLAB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Baird Financial Group's MLAB Position: Q3 2022 in Review

Baird Financial Group sold out of Mesa Laboratories (MLAB) in Q3 2022, closing a stake of 1,220 shares — an estimated $249K sold.

Baird Financial Group first reported a position in MLAB in Q3 2021 and held it in 4 quarters. The position peaked at $415K in Q4 2021. 163 funds tracked by Wall St. Rank hold MLAB as of Q3 2022.

  • Baird Financial Group reported no remaining Mesa Laboratories position as of Q3 2022 after selling out during the quarter.
  • Baird Financial Group sold 1,220 Mesa Laboratories shares in Q3 2022, an estimated $249K.
  • Baird Financial Group first reported a position in Mesa Laboratories in Q3 2021 and held it in 4 quarters.
  • Baird Financial Group's Mesa Laboratories position peaked at $415K in Q4 2021.
  • 163 funds tracked by Wall St. Rank held Mesa Laboratories as of Q3 2022.

Based on Baird Financial Group's 13F filing for Q3 2022, filed 15 Nov 2022.